Loading...

Astellas Pharma Inc.

ALPMF•PNK
Healthcare
Drug Manufacturers - General
$15.60
$0.07(0.48%)
U.S. Market opens in 13h 53m

Astellas Pharma Inc. (ALPMF) Stock Overview

Explore Astellas Pharma Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap27.9B
P/E Ratio13.75
EPS (TTM)$0.44
ROE0.20%
Fundamental Analysis

AI Price Forecasts

1 Month$15.77
3 Months$20.03
1 Year Target$13.72

ALPMF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Astellas Pharma Inc. (ALPMF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 46.91, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $13.72.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 13.75 and a market capitalization of 27.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.48%
5-Day Change
-0.95%
1-Month Change
-3.41%
3-Month Change
14.12%
6-Month Change
44.44%
Year-to-Date (YTD) Change
18.45%
1-Year Change
54.15%
3-Year Change
5.05%
5-Year Change
2.23%
All-Time (Max) Change
833233.33%

Contact Information

https://www.astellas.com
81 3 3244 3000
2-5-1, Nihonbashi-Honcho, Tokyo, NaN, 103-8411

Company Facts

14,754 Employees
IPO DateApr 26, 2010
CountryJP
Actively Trading

Frequently Asked Questions